Analysts Set Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) PT at $27.67

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) has earned a consensus rating of “Moderate Buy” from the six analysts that are covering the stock, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $27.67.

A number of analysts have recently weighed in on the stock. Wells Fargo & Company began coverage on shares of Kestra Medical Technologies in a report on Monday. They set an “overweight” rating and a $28.00 target price for the company. Piper Sandler started coverage on Kestra Medical Technologies in a research report on Monday. They issued an “overweight” rating and a $27.00 price objective on the stock. The Goldman Sachs Group started coverage on Kestra Medical Technologies in a report on Monday. They set a “neutral” rating and a $24.00 target price for the company. Bank of America assumed coverage on shares of Kestra Medical Technologies in a report on Monday. They issued a “buy” rating and a $30.00 price target on the stock. Finally, Stifel Nicolaus assumed coverage on shares of Kestra Medical Technologies in a report on Monday. They issued a “buy” rating and a $28.00 price objective for the company.

Kestra Medical Technologies Trading Up 4.6 %

Shares of KMTS opened at $25.70 on Monday. Kestra Medical Technologies has a twelve month low of $20.00 and a twelve month high of $26.06.

About Kestra Medical Technologies

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.